Fahradpour Mohsen, Keov Peter, Tognola Carlotta, Perez-Santamarina Estela, McCormick Peter J, Ghassempour Alireza, Gruber Christian W
Center for Physiology and Pharmacology, Medical University of ViennaVienna, Austria.
Medicinal Plants and Drugs Research Institute, Shahid Beheshti UniversityTehran, Iran.
Front Pharmacol. 2017 Sep 25;8:616. doi: 10.3389/fphar.2017.00616. eCollection 2017.
Cyclotides are plant derived, cystine-knot stabilized peptides characterized by their natural abundance, sequence variability and structural plasticity. They are abundantly expressed in Rubiaceae, Psychotrieae in particular. Previously the cyclotide kalata B7 was identified to modulate the human oxytocin and vasopressin G protein-coupled receptors (GPCRs), providing molecular validation of the plants' uterotonic properties and further establishing cyclotides as valuable source for GPCR ligand design. In this study we screened a cyclotide extract derived from the root powder of the South American medicinal plant ipecac () for its GPCR modulating activity of the corticotropin-releasing factor type 1 receptor (CRFR). We identified and characterized seven novel cyclotides. One cyclotide, caripe 8, isolated from the most active fraction, was further analyzed and found to antagonize the CRFR. A nanomolar concentration of this cyclotide (260 nM) reduced CRF potency by ∼4.5-fold. In contrast, caripe 8 did not inhibit forskolin-, or vasopressin-stimulated cAMP responses at the vasopressin V receptor, suggesting a CRFR-specific mode-of-action. These results in conjunction with our previous findings establish cyclotides as modulators of both classes A and B GPCRs. Given the diversity of cyclotides, our data point to other cyclotide-GPCR interactions as potentially important sources of drug-like molecules.
环肽是植物来源的、由胱氨酸结稳定的肽,其特点是天然丰度高、序列可变且结构可塑性强。它们在茜草科植物中大量表达,尤其是在九节属植物中。此前已鉴定出环肽卡拉塔B7可调节人类催产素和血管加压素G蛋白偶联受体(GPCR),为植物的子宫收缩特性提供了分子验证,并进一步确立了环肽作为GPCR配体设计的宝贵来源。在本研究中,我们筛选了一种从南美药用植物吐根的根粉中提取的环肽提取物,以研究其对促肾上腺皮质激素释放因子1型受体(CRFR)的GPCR调节活性。我们鉴定并表征了七种新型环肽。从活性最高的部分分离出的一种环肽卡里佩8,经过进一步分析发现它能拮抗CRFR。这种环肽的纳摩尔浓度(260 nM)使CRF的效力降低了约4.5倍。相比之下,卡里佩8在血管加压素V受体处不抑制福斯高林或血管加压素刺激的cAMP反应,表明其作用方式具有CRFR特异性。这些结果与我们之前的发现相结合,确立了环肽作为A类和B类GPCR的调节剂。鉴于环肽的多样性,我们的数据表明其他环肽与GPCR之间的相互作用可能是类药物分子的重要来源。